Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience

PURPOSE: High-dose-rate brachytherapy (HDR-BT) delivered in a single fraction as monotherapy is a potential treatment modality for low- and intermediate-risk prostate cancer (LIR-PC); however, outcome data with this technique remain limited. Here we describe our institutional HDR monotherapy experie...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Contemp Brachytherapy
Autori principali: Barnes, Justin M., Gabani, Prashant, Sanders, Max, Chundury, Anupama, Altman, Michael, Garcia-Ramirez, Jose, Li, Harold, Zoberi, Jacqueline E., Baumann, Brian C., Gay, Hiram A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Termedia Publishing House 2019
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6854868/
https://ncbi.nlm.nih.gov/pubmed/31749847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2019.89367
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi